Global Biopharmaceutical 3PL Market Size, Status and Forecast 2024-2034
Global Biopharmaceutical 3PL Scope and Market Size
Biopharmaceutical 3PL market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical 3PL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cold Chain
Non-cold Chain
Segment by Application
Transportation
Warehousing and Storage
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
FedEx.
DHL International GmbH
SF Express
United Parcel Service of America, Inc.
AmerisourceBergen Corporation
DB Schenker
KUEHNE + NAGEL
Kerry Logistics Network Limited
Agility
EMS
SF Express
Jd.Com, Inc.

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical 3PL Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cold Chain
1.2.3 Non-cold Chain
1.3 Market by Application
1.3.1 Global Biopharmaceutical 3PL Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Transportation
1.3.3 Warehousing and Storage
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical 3PL Market Perspective (2016-2027)
2.2 Biopharmaceutical 3PL Growth Trends by Regions
2.2.1 Biopharmaceutical 3PL Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceutical 3PL Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceutical 3PL Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceutical 3PL Industry Dynamic
2.3.1 Biopharmaceutical 3PL Market Trends
2.3.2 Biopharmaceutical 3PL Market Drivers
2.3.3 Biopharmaceutical 3PL Market Challenges
2.3.4 Biopharmaceutical 3PL Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical 3PL Players by Revenue
3.1.1 Global Top Biopharmaceutical 3PL Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceutical 3PL Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceutical 3PL Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical 3PL Revenue
3.4 Global Biopharmaceutical 3PL Market Concentration Ratio
3.4.1 Global Biopharmaceutical 3PL Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical 3PL Revenue in 2020
3.5 Biopharmaceutical 3PL Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical 3PL Product Solution and Service
3.7 Date of Enter into Biopharmaceutical 3PL Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical 3PL Breakdown Data by Type
4.1 Global Biopharmaceutical 3PL Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceutical 3PL Forecasted Market Size by Type (2022-2027)
5 Biopharmaceutical 3PL Breakdown Data by Application
5.1 Global Biopharmaceutical 3PL Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceutical 3PL Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biopharmaceutical 3PL Market Size (2016-2027)
6.2 North America Biopharmaceutical 3PL Market Size by Type
6.2.1 North America Biopharmaceutical 3PL Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceutical 3PL Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceutical 3PL Market Size by Type (2016-2027)
6.3 North America Biopharmaceutical 3PL Market Size by Application
6.3.1 North America Biopharmaceutical 3PL Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceutical 3PL Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceutical 3PL Market Size by Application (2016-2027)
6.4 North America Biopharmaceutical 3PL Market Size by Country
6.4.1 North America Biopharmaceutical 3PL Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceutical 3PL Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceutical 3PL Market Size (2016-2027)
7.2 Europe Biopharmaceutical 3PL Market Size by Type
7.2.1 Europe Biopharmaceutical 3PL Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceutical 3PL Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceutical 3PL Market Size by Type (2016-2027)
7.3 Europe Biopharmaceutical 3PL Market Size by Application
7.3.1 Europe Biopharmaceutical 3PL Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceutical 3PL Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceutical 3PL Market Size by Application (2016-2027)
7.4 Europe Biopharmaceutical 3PL Market Size by Country
7.4.1 Europe Biopharmaceutical 3PL Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceutical 3PL Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical 3PL Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceutical 3PL Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceutical 3PL Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceutical 3PL Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical 3PL Market Size (2016-2027)
9.2 Latin America Biopharmaceutical 3PL Market Size by Type
9.2.1 Latin America Biopharmaceutical 3PL Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceutical 3PL Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceutical 3PL Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceutical 3PL Market Size by Application
9.3.1 Latin America Biopharmaceutical 3PL Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceutical 3PL Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceutical 3PL Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceutical 3PL Market Size by Country
9.4.1 Latin America Biopharmaceutical 3PL Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceutical 3PL Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical 3PL Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceutical 3PL Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceutical 3PL Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceutical 3PL Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 FedEx.
11.1.1 FedEx. Company Details
11.1.2 FedEx. Business Overview
11.1.3 FedEx. Biopharmaceutical 3PL Introduction
11.1.4 FedEx. Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.1.5 FedEx. Recent Development
11.2 DHL International GmbH
11.2.1 DHL International GmbH Company Details
11.2.2 DHL International GmbH Business Overview
11.2.3 DHL International GmbH Biopharmaceutical 3PL Introduction
11.2.4 DHL International GmbH Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.2.5 DHL International GmbH Recent Development
11.3 SF Express
11.3.1 SF Express Company Details
11.3.2 SF Express Business Overview
11.3.3 SF Express Biopharmaceutical 3PL Introduction
11.3.4 SF Express Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.3.5 SF Express Recent Development
11.4 United Parcel Service of America, Inc.
11.4.1 United Parcel Service of America, Inc. Company Details
11.4.2 United Parcel Service of America, Inc. Business Overview
11.4.3 United Parcel Service of America, Inc. Biopharmaceutical 3PL Introduction
11.4.4 United Parcel Service of America, Inc. Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.4.5 United Parcel Service of America, Inc. Recent Development
11.5 AmerisourceBergen Corporation
11.5.1 AmerisourceBergen Corporation Company Details
11.5.2 AmerisourceBergen Corporation Business Overview
11.5.3 AmerisourceBergen Corporation Biopharmaceutical 3PL Introduction
11.5.4 AmerisourceBergen Corporation Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.5.5 AmerisourceBergen Corporation Recent Development
11.6 DB Schenker
11.6.1 DB Schenker Company Details
11.6.2 DB Schenker Business Overview
11.6.3 DB Schenker Biopharmaceutical 3PL Introduction
11.6.4 DB Schenker Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.6.5 DB Schenker Recent Development
11.7 KUEHNE + NAGEL
11.7.1 KUEHNE + NAGEL Company Details
11.7.2 KUEHNE + NAGEL Business Overview
11.7.3 KUEHNE + NAGEL Biopharmaceutical 3PL Introduction
11.7.4 KUEHNE + NAGEL Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.7.5 KUEHNE + NAGEL Recent Development
11.8 Kerry Logistics Network Limited
11.8.1 Kerry Logistics Network Limited Company Details
11.8.2 Kerry Logistics Network Limited Business Overview
11.8.3 Kerry Logistics Network Limited Biopharmaceutical 3PL Introduction
11.8.4 Kerry Logistics Network Limited Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.8.5 Kerry Logistics Network Limited Recent Development
11.9 Agility
11.9.1 Agility Company Details
11.9.2 Agility Business Overview
11.9.3 Agility Biopharmaceutical 3PL Introduction
11.9.4 Agility Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.9.5 Agility Recent Development
11.10 EMS
11.10.1 EMS Company Details
11.10.2 EMS Business Overview
11.10.3 EMS Biopharmaceutical 3PL Introduction
11.10.4 EMS Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.10.5 EMS Recent Development
11.11 SF Express
11.11.1 SF Express Company Details
11.11.2 SF Express Business Overview
11.11.3 SF Express Biopharmaceutical 3PL Introduction
11.11.4 SF Express Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.11.5 SF Express Recent Development
11.12 Jd.Com, Inc.
11.12.1 Jd.Com, Inc. Company Details
11.12.2 Jd.Com, Inc. Business Overview
11.12.3 Jd.Com, Inc. Biopharmaceutical 3PL Introduction
11.12.4 Jd.Com, Inc. Revenue in Biopharmaceutical 3PL Business (2016-2021)
11.12.5 Jd.Com, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details